Live Breaking News & Updates on Symbio Pharmaceuticals
Stay updated with breaking news from Symbio pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lipella Pharmaceuticals (NASDAQ:LIPO – Get Free Report) and Chimerix (NASDAQ:CMRX – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations and earnings. Insider and Institutional Ownership 74.3% of Lipella Pharmaceuticals […] ....
Chimerix Sells Smallpox Countermeasure to Emergent to Focus on Rare Cancer Drug Development globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
Chimerix is selling global rights to smallpox drug Tembexa, the biotech’s only FDA-approved product, as a way to fund clinical development of a therapy in pivotal testing for a rare type of brain cancer. The deal marks Chimerix’s nearly complete departure from the antiviral work that defined the company for most of its history. ....
Emergent BioSolutions to acquire smallpox treatment from Chimerix - Baltimore Business Journal bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.